NDC 51079-938

Terazosin Hydrochloride Anhydrous

Terazosin Hydrochloride Anhydrous

Terazosin Hydrochloride Anhydrous is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Terazosin Hydrochloride Anhydrous.

• Product ID: 51079-938_7d8ee118-56fe-08c9-e053-2a91aa0ae10f
• NDC: 51079-938
• Product Type: Human Prescription Drug
• Proprietary Name: Terazosin Hydrochloride Anhydrous
• Generic Name: Terazosin Hydrochloride Anhydrous
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2000-04-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA075140
• Labeler Name: Mylan Institutional Inc.
• Substance Name: TERAZOSIN HYDROCHLORIDE ANHYDROUS
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51079-938-20

100 BLISTER PACK in 1 CARTON (51079-938-20) > 1 CAPSULE in 1 BLISTER PACK (51079-938-01)

• Marketing Start Date: 2000-04-01
• Marketing End Date: 2021-02-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51079-938-01 [51079093801]

Terazosin Hydrochloride Anhydrous CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA075140
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2000-04-01
• Marketing End Date: 2021-02-28

NDC 51079-938-20 [51079093820]

Terazosin Hydrochloride Anhydrous CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA075140
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2000-04-01
• Marketing End Date: 2021-02-28

Drug Details

Active Ingredients

Ingredient	Strength
TERAZOSIN HYDROCHLORIDE ANHYDROUS	5 mg/1

OpenFDA Data

• SPL SET ID: 24a4243f-0855-44c1-bb78-ba6f14b273f9
• Manufacturer:
  • Mylan Institutional Inc.
• UNII:
  • 8QOP8Z9955
• RxNorm Concept Unique ID - RxCUI:
  • 313217
  • 313215
  • 313219

Pharmacological Class

• Adrenergic alpha-Antagonists [MoA]
• alpha-Adrenergic Blocker [EPC]

Medicade Reported Pricing

51079093820 TERAZOSIN 5 MG CAPSULE

Pricing Unit: EA | Drug Type:

51079093801 TERAZOSIN 5 MG CAPSULE

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Terazosin Hydrochloride Anhydrous" or generic name "Terazosin Hydrochloride Anhydrous"

NDC	Brand Name	Generic Name
0378-1570	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
0378-2260	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
0378-2264	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
0378-2268	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
43063-495	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
51079-936	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
51079-937	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
51079-938	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous
71335-0787	Terazosin Hydrochloride Anhydrous	terazosin hydrochloride anhydrous